METHYLENE BLUE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methylene Blue, and what generic alternatives are available?
Methylene Blue is a drug marketed by Zydus and is included in one NDA.
The generic ingredient in METHYLENE BLUE is methylene blue. There are twenty-five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the methylene blue profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methylene Blue
A generic version of METHYLENE BLUE was approved as methylene blue by ZYDUS on December 5th, 2023.
Summary for METHYLENE BLUE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 127 |
| Clinical Trials: | 109 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for METHYLENE BLUE |
| DailyMed Link: | METHYLENE BLUE at DailyMed |
Recent Clinical Trials for METHYLENE BLUE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | N/A |
| Mashhad University of Medical Sciences | Early Phase 1 |
| Nanjing First Hospital, Nanjing Medical University | Phase 3 |
Pharmacology for METHYLENE BLUE
| Drug Class | Oxidation-Reduction Agent |
| Mechanism of Action | Oxidation-Reduction Activity |
Medical Subject Heading (MeSH) Categories for METHYLENE BLUE
US Patents and Regulatory Information for METHYLENE BLUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus | METHYLENE BLUE | methylene blue | SOLUTION;INTRAVENOUS | 215636-001 | Dec 5, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Zydus | METHYLENE BLUE | methylene blue | SOLUTION;INTRAVENOUS | 215636-002 | Dec 5, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
